The Controversy Over the FDA’s Approval of The First Alzheimer’s Treatment Keeps Growing

Дата публікації:
11/06/2021 18:34

Постійна адреса новини:
http://www.vsinovyny.com/7940540

11/06/2021 18:34 // TIME.com: Top Stories

More experts are criticizing the FDA’s decision to approve aducanumab

«	Наступна новина з архіву In Netflix’s Tender and Exhilarating Skater Girl, a Shy Indian Teenager Takes Flight on a Board with Wheels	Попередня новина з архіву Party’s over: Amsterdam plans to keep tourists ‘in penis outfits’ away	»